摘要
通过1例急性冠脉综合征(Acute Coronary Syndrome,ACS)患者经皮冠状动脉介入治疗术(Percutaneous Coronary Intervention,PCI)后支架内血栓形成(Intrastent Thrombosis,IST)病例,临床药师分析患者IST的可能原因并参与药物治疗方案调整及全程化药学服务,旨在提高患者的药物治疗效果,减少并发症,从而改善患者预后,体现了临床药师在临床用药治疗中的价值。
Through a case of acute coronary syndrome(ACS)after percutaneous coronary intervention(PCI)caused by intrastent thrombosis(IST),clinical pharmacists analyze the possible cause of IST and participate in the adjustment of drug treatment and provide comprehensive pharmaceutical services,intended to improve medication treatment effect,reduce complications,and ultimately improve the patient′s prognosis.This reflects the value of clinical pharmacists in clinical medication treatment.
作者
卢嘉丽
杨贤
张红梅
杨丽宁
陈宇
李炀
LU Jia-li;YANG Xian;ZHANG Hong-mei;YANG Li-ning;CHEN Yu;LI Yang(Department of pharmacy,Second Provincial People′s Hospital of Gansu,Lanzhou 730030,China;Department of Pharmacy,Nanjing Drum Tower Hospital,the Affiliated Hospital of Nanjing University Medical School,Nanjing 210008,China)
出处
《海峡药学》
2024年第5期80-82,共3页
Strait Pharmaceutical Journal
关键词
支架内血栓形成
氯吡格雷抵抗
临床药师
药学监护
替格瑞洛
In-stent thrombosis
Clopidogrel resistance
Clinical pharmacists
Pharmaceutical care
Ticagrelor
